Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failure

Nephron

Volumn 90, Issue 1, 2002, Pages 64-71

  Kawanaka, Norikuni ^a   Nagake, Yoshio ^a   Yamamura, Masahiro ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

CD14+CD16+ monocytes; Chronic renal failure; Fc gamma receptor III; Hemodialysis; Macrophage colony stimulating factor; Soluble CD14

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; CD16 ANTIGEN; FC RECEPTOR; POLYSULFONE; RECEPTOR SUBUNIT;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BIOCOMPATIBILITY; BLOOD CELL; BLOOD LEVEL; CELL ACTIVATION; CELL POPULATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; HUMAN CELL; MALE; MONOCYTE; PRIORITY JOURNAL; STAINING;

ADULT; ANTIGENS, CD14; FEMALE; FLOW CYTOMETRY; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, IGG; RENAL DIALYSIS;

EID: 0036138285     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046316     Document Type: Article

References (37)

1. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis
2. Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glucoprotein Mac-1
3. Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis
4. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis
5. Granulocyte activation and ashesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane
6. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement
7. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis
8. Induction of tumour necrosis factor-alpha during haemodialysis. Influence of the membrane type
9. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes
10. Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS)
11. Differential cytokine expression in human blood monocyte subpopulations: A polymerase chain reaction analysis
12. CD14low CD16high: A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection
13. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients
14. Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta
15. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients
16. CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes
17. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages
18. Generalized immune activation in pulmonary tuberculosis: Co-activation with HIV infection
19. CD16+ monocytes in patients with cancer: Spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor
20. Blood-membrane interaction in hemodialysis leads to increased cytokine production
21. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis
22. Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from gran-negative bacteria
23. Endotoxin tolerance: Regulation of cytokine production and cellular changes in response to endotoxin application in cancer patients
24. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates
25. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta
26. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia
27. Biocompatibility of different hemodialysis and plasmapheresis membranes
28. Effect of permeability on indices of haemodialysis membrane biocompatibility
29. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14
30. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes
31. The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes
32. Human monocyte CD14 is upregulated by lipopolysaccharide
33. Serum CD14 levels in polytraumatized and severely burned patients
34. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: Evidence for chronic exposure to LPS
35. Changes in CD14 expression on monocytes and serum soluble CD14 level during hemodialyisis
36. Chronic and intradialytic effects of high-flux hemodialysis on tumor necrosis factor-alpha production: Relationship to endotoxins
37. In vivo induction of interleukin-1 during hemodialysis